Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time
- PMID: 22505475
- PMCID: PMC3341312
- DOI: 10.1093/jnci/djs203
Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time
Comment on
-
A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy.J Natl Cancer Inst. 2012 May 2;104(9):670-81. doi: 10.1093/jnci/djs177. Epub 2012 Apr 13. J Natl Cancer Inst. 2012. PMID: 22505474 Free PMC article.
References
-
- American Cancer Society. http://www.cancer.org/Cancer/OvarianCancer/DetailedGuide/ovarian-cancer-... Accessed March 27, 2012.
-
- van Altena AM, Kolwijck E, Spanjer MJ, et al. CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study. Gynecol Oncol. 2010;119(2):265–269. - PubMed
-
- Juretzka MM, Barakat RR, Chi DS, et al. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Gynecol Oncol. 2007;104(1):176–180. - PubMed
-
- Gadducci A, Zola P, Landoni F, et al. Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gynecol Oncol. 1995;58(1):42–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical